Industry News
GenePharma appoints Sapphire Bioscience as ANZ distributor
Sapphire Bioscience has been appointed as the exclusive distributor of GenePharma products in Australia and New Zealand. GenePharma is a Shanghai-based company that specialises in the synthesis of RNAi including siRNA, miRNA and related products. [ + ]
In vitro skin test to replace animal testing
Scientists from Baxter Laboratories have developed an in vitro skin test that could work alongside other alternative methods to help replace animals such as rabbits and guinea pigs in testing for cosmetics and pharmaceuticals. [ + ]
Alchemia enters analysis stage for mCRC trial
Alchemia (ASX:ACL) expects to be ready to announce the results of its key phase III trial of HA-Irinotecan in metastatic colorectal cancer by the end of the month.
[ + ]Eye Co gets European patent for eye disease drug
Melbourne's Eye Co has picked up a European patent covering a new class of steroids to treat diabetic eye disease.
[ + ]Three new Grand Challenges announced
One decade after the Bill & Melinda Gates Foundation launched the Grand Challenges in Global Health grant program, a group of international partners has funded three new challenges aimed at creating breakthroughs in science. [ + ]
Protein for DNA repair says cheese
UK scientists have taken pictures of the BRCA2 protein, which is involved in DNA repair, for the first time. [ + ]
Turn your smartphone into a cosmic ray detector
Researchers from the University of Wisconsin-Madison have developed a smartphone app that can turn Android phones into detectors to capture the light particles created when cosmic rays crash into Earth's atmosphere. [ + ]
BD acquires CareFusion for US$12.2bn
Healthcare company CareFusion has been acquired by Becton, Dickinson and Company (BD) for $58 per share in cash and stock - a total of $12.2 billion. [ + ]
Blood test for hay fever
Brisbane researchers have developed a blood test that can accurately detect an allergy to Bahia grass - one of the most common causes of hay fever. [ + ]
Ultrarapid insulin could revolutionise type 1 diabetes treatment
A director with research and consulting firm GlobalData has claimed that ultrarapid formulations of the currently marketed rapid-acting insulin analogues have the potential to radically change the insulin market over the next five years. [ + ]
Analytica raising $4m for PeriCoach launch
Analytica (ASX:ALT) has secured a CE Mark for its PeriCoach device and has launched an up to $4m capital raising to help fund marketing ahead of its formal launch in Australia. [ + ]
Citizen scientists assist whale migration research
The East Coast Whale Watch Catalogue has collated hundreds of photographs of humpback whales along Australia's east coast - many of which have been taken by citizen scientists. [ + ]
Roche acquires AbVitro technology
Healthcare company Roche has announced a technology acquisition from AbVitro, a company focused on therapeutic target discovery. Roche obtained exclusive rights to a primer extension-based target enrichment (PETE) technology and associated patent applications filed by AbVitro. [ + ]
Annual Report 2014: AusBiotech "facilitating global development"
The AusBiotech Annual Report 2014 is now available, detailing how AusBiotech is delivering on its plan to facilitate global development of the Australian life sciences industry.
[ + ]BVA's bionic eye implant shown to be safe
Bionic Vision Australia's (BVA) prototype 24-channel percutaneous connector implant was found to be safe during its first clinical trial in retinosis pigmentosa. [ + ]
